Page last updated: 2024-08-25

zoledronic acid and Glomerulonephritis

zoledronic acid has been researched along with Glomerulonephritis in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Daphnis, E; Georgoulias, V; Giannakakis, K; Kokologiannakis, G; Kroustalakis, N; Liotsi, C; Lioudaki, E; Papadimitraki, E; Stylianou, K	1
McKenna, KE; Morris, TC; Ramadan, KM	1

Other Studies

2 other study(ies) available for zoledronic acid and Glomerulonephritis

Article	Year
Crescentic glomerulonephritis associated with vascular endothelial growth factor (VEGF) inhibitor and bisphosphonate administration. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2011, Volume: 26, Issue:5 Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Bone Density Conservation Agents; Diphosphonates; Drug Therapy, Combination; Glomerulonephritis; Humans; Imidazoles; Lung Neoplasms; Male; Renal Dialysis; Small Cell Lung Carcinoma; Treatment Outcome; Vascular Endothelial Growth Factor A; Zoledronic Acid	2011
Clinical response of cutaneous squamous-cell carcinoma to bortezomib given for myeloma. The Lancet. Oncology, 2006, Volume: 7, Issue:11 Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Carcinoma, Squamous Cell; Clarithromycin; Dexamethasone; Diphosphonates; Glomerulonephritis; Humans; Idarubicin; Imidazoles; Immunosuppressive Agents; Male; Melphalan; Middle Aged; Multiple Myeloma; Nephrotic Syndrome; Pamidronate; Protein Synthesis Inhibitors; Pyrazines; Skin Neoplasms; Thalidomide; Zoledronic Acid	2006

Article

Year

Crescentic glomerulonephritis associated with vascular endothelial growth factor (VEGF) inhibitor and bisphosphonate administration.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2011, Volume: 26, Issue:5

Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Bone Density Conservation Agents; Diphosphonates; Drug Therapy, Combination; Glomerulonephritis; Humans; Imidazoles; Lung Neoplasms; Male; Renal Dialysis; Small Cell Lung Carcinoma; Treatment Outcome; Vascular Endothelial Growth Factor A; Zoledronic Acid

2011

Clinical response of cutaneous squamous-cell carcinoma to bortezomib given for myeloma.

The Lancet. Oncology, 2006, Volume: 7, Issue:11

Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Carcinoma, Squamous Cell; Clarithromycin; Dexamethasone; Diphosphonates; Glomerulonephritis; Humans; Idarubicin; Imidazoles; Immunosuppressive Agents; Male; Melphalan; Middle Aged; Multiple Myeloma; Nephrotic Syndrome; Pamidronate; Protein Synthesis Inhibitors; Pyrazines; Skin Neoplasms; Thalidomide; Zoledronic Acid

2006